The Predictive Value of p53, p27Kip1, and α-Catenin for Progression in Superficial Bladder Carcinoma
- 31 July 2006
- journal article
- Published by Elsevier BV in European Urology
- Vol. 50 (1), 76-82
- https://doi.org/10.1016/j.eururo.2005.12.041
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Metastasis Markers in Bladder Cancer: A Review of the Literature and Clinical ConsiderationsEuropean Urology, 2004
- Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for TherapyEuropean Urology, 2004
- The p53 Tumor Suppressor Gene and Nuclear Protein: Basic Science Review and Relevance in the Management of Bladder CancerJournal of Urology, 2003
- Revised Classification of Urothelial NeoplasmsThe American Journal of Surgical Pathology, 2000
- CORRELATION AND PROGNOSTIC SIGNIFICANCE OF p53, p21 WAF1/CIP1 AND Ki-67 EXPRESSION IN PATIENTS WITH SUPERFICIAL BLADDER TUMORS TREATED WITH BACILLUS CALMETTE-GUERIN INTRAVESICAL THERAPYJournal of Urology, 1999
- p53 Gene Mutation in Recurrent Superficial Bladder CancerJournal of Urology, 1995
- Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease ProgressionJNCI Journal of the National Cancer Institute, 1993
- P53 in tumour pathology: Can we trust immunocytochemistry?The Journal of Pathology, 1992
- p53 Mutations in Human CancersScience, 1991